Displaying drugs 10951 - 10975 of 12697 in total
Methylthioinosine
An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position.
Experimental
Matched Description: … An analog of inosine with a methylthio group replacing the hydroxyl group in the 6-position. …
Neflamapimod
Neflamapimod has been used in trials studying the treatment of Alzheimer's Disease and Mild Cognitive Impairment.
Investigational
Matched Description: … Neflamapimod has been used in trials studying the treatment of Alzheimer's Disease and Mild Cognitive …
Vilaprisan
Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I.
Investigational
Matched Description: … Vilaprisan has been used in trials studying the treatment of Leiomyoma and Clinical Trial, Phase I. …
Ozone
Ozone has been used in trials studying the treatment of Mild Asthma and Primary Apical Periodontite.
Investigational
Matched Description: … Ozone has been used in trials studying the treatment of Mild Asthma and Primary Apical Periodontite. …
Senrebotase
Senrebotase has been used in trials studying the treatment of Neuralgia, Postherpetic and Urinary Bladder, Overactive.
Investigational
Matched Description: … Senrebotase has been used in trials studying the treatment of Neuralgia, Postherpetic and Urinary Bladder …
BK-MDA
BK-MDA has been used in trials studying the treatment of Bladder Exstrophy and Urinary Incontinence.
Investigational
Matched Description: … BK-MDA has been used in trials studying the treatment of Bladder Exstrophy and Urinary Incontinence. …
Falnidamol
Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Description: … Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol …
JHU-75528 C-11
JHU-75528 C-11 is under investigation in clinical trial NCT03204305 (Brain Imaging of Cannabinoid Receptors).
Investigational
Matched Description: … JHU-75528 C-11 is under investigation in clinical trial NCT03204305 (Brain Imaging of Cannabinoid Receptors …
Nafithromycin
Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP).
Investigational
Matched Description: … Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin …
Uzansertib
Uzansertib is under investigation in clinical trial NCT02587598 (Study of INCB053914 in Subjects With Advanced Malignancies).
Investigational
Matched Description: … Uzansertib is under investigation in clinical trial NCT02587598 (Study of INCB053914 in Subjects With …
AMT-080
AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.
Investigational
Matched Description: … AMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular …
DYN-101
DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein.
Investigational
Matched Description: … DYN-101 is an antisense product candidate designed to reduce the expression of dynamin 2 protein. …
Suvodirsen
Suvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular dystrophy.
Investigational
Matched Description: … Suvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular …
PLG-0206
PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.
Investigational
Matched Description: … PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections …
MTL-CEBPA
MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide.
Investigational
Matched Description: … MTL-CEBPA is a SMARTICLES liposomal formulation of MTL-501, a small activating RNA (saRNA) oligonucleotide …
Ligustrazine
Ligustrazine is under investigation in clinical trial NCT05942352 (Clinical Study of Ligustrazine in Treating Alcohol Addiction).
Investigational
Matched Description: … Ligustrazine is under investigation in clinical trial NCT05942352 (Clinical Study of Ligustrazine in …
Sanfetrinem cilexetil
Sanfetrinem cilexetil is under investigation in clinical trial NCT05388448 (EBA, Safety and Tolerability of Sanfetrinem Cilexetil).
Investigational
Matched Description: … Sanfetrinem cilexetil is under investigation in clinical trial NCT05388448 (EBA, Safety and Tolerability of …
Sifalimumab
Sifalimumab is a fully human monoclonal antibody targeting interferon-alpha. The levels of interferon-alpha are elevated in many patients with active systemic lupus erythematosus (SLE, or lupus) and other autoimmune disorders, and may be associated with disease activity. Sifalimumab may suppress the abnormal immune activity associated with lupus by binding to...
Investigational
Matched Description: … The levels of interferon-alpha are elevated in many patients with active systemic lupus erythematosus ... immune activity associated with lupus by binding to multiple interferon-alpha subtypes seen in the serum of …
ISIS 113715
ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant
reductions in LDL-cholesterol.
Investigational
Matched Description: … , for the treatment of type 2 diabetes. ... ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b ... In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose …
RUS 3108
RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and stroke by Dr. Reddy’s Laboratories.
The drug’s Phase I clinical trials have been initiated in Europe to assess safety of the drug compound in healthy volunteers.
Investigational
Matched Description: … RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of cardiovascular disorders ... The drug’s Phase I clinical trials have been initiated in Europe to assess safety of the drug compound …
VY-HTT01
VY-HTT01 is a gene therapy designed to reduce the expression of huntingtin, thereby altering disease progression. VY-HTT01 is comprised of an adeno-associated virus capsid (AAV1) and a proprietary transgene that harnesses the canonical RNA interference pathway to selectively knock down levels of HTT mRNA.
Investigational
Matched Description: … the canonical RNA interference pathway to selectively knock down levels of HTT mRNA. ... VY-HTT01 is a gene therapy designed to reduce the expression of huntingtin, thereby altering disease ... VY-HTT01 is comprised of an adeno-associated virus capsid (AAV1) and a proprietary transgene that harnesses …
Amolimogene
Amolimogene is an investigational therapeutic designed to specifically augment the body's defensive response to human papillomavirus (HPV). Amolimogene was biologically engineered as a targeted therapy for the treatment of cervical dysplasia.
Investigational
Matched Description: … Amolimogene was biologically engineered as a targeted therapy for the treatment of cervical dysplasia …
Tridihexethyl
Tridihexethyl is a synthetic anticholinergic agent which has been shown in experimental and clinical studies to have a pronounced antispasmodic and antisecretory effect on the gastrointestinal tract. Tridihexethyl is an antimuscarinic, anticholinergic drug. Tridihexethyl is no longer available in the US market.
Withdrawn
scyllo-inositol
An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Scyllitol has...
Investigational
Matched Description: … Scyllitol has been investigated for the treatment of Alzheimer Disease. ... An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain …
QR-334
QR-334 is under investigation for the treatment of sialorrhea. Sialorrhea is an excess secretion of saliva produced by the salivary glands, resulting in drooling. No pharmaceutical interventions currently exist to treat sialorrhea. The symptom is associated with many diseases including Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s Disease,...
Investigational
Matched Description: … QR-334 is under investigation for the treatment of sialorrhea. ... Sialorrhea is an excess secretion of saliva produced by the salivary glands, resulting in drooling. …
Displaying drugs 10951 - 10975 of 12697 in total